{"version":"1.0","type":"link","title":"Efficacy and safety of pembrolizumab with or without lenvatinib in recurrent uterine carcinosarcoma: a real-world single-center study.","author_name":"Lim S 외","author_url":"https://prs-insight.online/author/Lim%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/169277","thumbnail_width":1200,"thumbnail_height":630}